Iradimed Corp (OQ:IRMD)

May 02, 2024 08:30 am ET
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months ended March 31, 2024. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the...
Apr 25, 2024 04:05 pm ET
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at...
Mar 13, 2024 04:30 pm ET
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live...
Feb 08, 2024 08:05 am ET
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months and year ended December 31, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical...
Feb 01, 2024 04:05 pm ET
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day...
Jan 09, 2024 08:30 am ET
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023....
Jan 02, 2024 04:30 pm ET
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P. Morgan...
Dec 12, 2023 10:00 am ET
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The...
Nov 30, 2023 09:00 am ET
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”)...
Nov 03, 2023 08:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical...
Oct 26, 2023 04:05 pm ET
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3rd. IRADIMED management will host a conference call the same day beginning at...
Sep 06, 2023 04:00 pm ET
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the H.C. Wainwright 25th...
Aug 03, 2023 08:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three and six months ended June 30, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...
Jul 27, 2023 08:45 am ET
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market opens on Thursday, August 3rd. Iradimed management will host a conference call the same day beginning at...
May 10, 2023 08:30 am ET
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), was recently named on Forbes’ latest list of America’s Best Small Companies for 2023. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and...
May 04, 2023 08:30 am ET
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and...
Apr 27, 2023 08:30 am ET
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market opens on Thursday, May 4th. Iradimed management will host a conference call the same day beginning at...
Mar 06, 2023 08:45 am ET
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live...
Feb 24, 2023 04:15 pm ET
IRADIMED CORPORATION Issues Urgent Medical Device Correction
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a potential issue with some 1057 Syringe Adapter Sets related to the syringe venting function during use which can...
Feb 02, 2023 08:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the fourth quarter and year ended December 31, 2022. The Company also announced that its Board of Directors approved a special cash dividend of $1.05 per...
Jan 26, 2023 10:30 am ET
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023.  IRADIMED management will host a conference call the same day...
Jan 18, 2023 08:00 am ET
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced selected preliminary financial results for the fourth quarter that ended December 31, 2022. Fourth-quarter revenue is expected to be approximately $14.9 million, up 25% from the...
Nov 03, 2022 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2022. The Company is a leader in the development of innovative magnetic resonance imaging ("MRI") medical...
Oct 27, 2022 08:00 am ET
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIMED management will host a conference call the same day beginning at...
Oct 10, 2022 08:00 am ET
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pump. Roger Susi, President and Chief Executive Officer of the...
Oct 06, 2022 04:05 pm ET
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced the appointment of Hilda Scharen-Guivel to the Iradimed Board of Directors, effective October 4, 2022. Following the appointment of Ms. Scharen-Guivel, the Board will comprise five...
Jul 29, 2022 11:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three and six months ended June 30, 2022. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...
Jul 28, 2022 01:56 pm ET
UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day beginning at...
Jul 22, 2022 04:30 pm ET
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day beginning at...
May 26, 2022 04:05 pm ET
IRADIMED Names John F. Glenn Chief Financial Officer
IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and finance, including...
Apr 29, 2022 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and...
Apr 28, 2022 04:00 pm ET
IRADIMED CORPORATION Announces Executive Transition
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resigned from the Company effective May 27, 2022. Mr. Scott started at the Company in December 2013 and is...
Apr 05, 2022 07:00 am ET
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market opens on Friday, April 29th. IRADIMED management will host a conference call the same day beginning at...
Feb 07, 2022 04:05 pm ET
IRADIMED Announces Special $1.00 Per Share Cash Dividend
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share on the Company’s outstanding common stock. This special cash dividend is payable on February 24, 2022 to...
Feb 04, 2022 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and...
Jan 20, 2022 07:00 am ET
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market opens on Friday, February 4th. IRADIMED management will host a conference call the same day beginning at...
Oct 29, 2021 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and...
Oct 08, 2021 07:00 am ET
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29th. IRADIMED management will host a conference call the same day beginning at...
Jul 30, 2021 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and...
Jul 07, 2021 07:00 am ET
IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market opens on Friday, July 30th. IRADIMED management will host a conference call the same day beginning at...
Apr 30, 2021 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and...
Apr 09, 2021 07:00 am ET
IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market opens on Friday, April 30th. IRADIMED management will host a conference call the same day beginning at...
Feb 04, 2021 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and...
Jan 27, 2021 07:00 am ET
IRADIMED CORPORATION to Hold 2020 Fourth Quarter Financial Results Conference Call on February 4th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market opens on Thursday, February 4th. IRADIMED management will host a conference call the same day beginning at...
Oct 30, 2020 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results
iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic...
Oct 08, 2020 07:00 am ET
IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens on Friday, October 30th. IRADIMED management will host a conference call the same day beginning at...
Jul 30, 2020 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results
iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic...
Jul 16, 2020 07:00 am ET
IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market opens on Thursday, July 30th. IRADIMED management will host a conference call the same day beginning at...
May 29, 2020 07:00 am ET
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer
IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s President and Chief Executive Officer after the departure of Leslie McDonnell, who separated from the...
May 11, 2020 07:00 am ET
IRADIMED CORPORATION Announces Issuance of U.S. Patent
IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on previous claims pertaining to the wireless remote control of IV infusion pumps. The patent for invention...
Apr 30, 2020 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2020 Financial Results
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic...
Apr 16, 2020 07:00 am ET
IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before the market opens on Thursday, April 30th. iRadimed management will host a conference call the same day beginning at...
Apr 07, 2020 07:00 am ET
IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19
IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is withdrawing its first quarter and full year 2020 financial guidance due to the uncertainty created by...
Mar 12, 2020 07:00 am ET
IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development
IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President and Chief Executive Officer. “Lynn is...
Mar 06, 2020 09:50 am ET
IRADIMED CORPORATION to Present at the 32nd Annual Roth Conference
IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32nd Annual Roth Conference in Laguna Niguel, CA.  Ms. McDonnell is scheduled to present on Monday, March 16th at...
Feb 26, 2020 07:00 am ET
IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of Regulatory Affairs and Quality Assurance
IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company’s regulatory efforts since 2004. IRADIMED appointed Steven...
Feb 06, 2020 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Jan 22, 2020 07:00 am ET
IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 fourth quarter financial results before the market opens on Thursday, February 6th. IRADIMED management will host a conference call the same day beginning at...
Jan 07, 2020 07:00 am ET
IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales
IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company’s commercial efforts since 2012. IRADIMED appointed...
Dec 12, 2019 08:55 am ET
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Oct 30, 2019 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Oct 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30th. IRADIMED management will host a conference call the same day beginning at...
Oct 08, 2019 07:00 am ET
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter. “The resolution of the warning letter is the result...
Aug 27, 2019 04:15 pm ET
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer, will participate in the Morgan Stanley...
Jul 30, 2019 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results
iRadimed Corporation (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Jul 29, 2019 04:00 pm ET
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step down as President and CEO on August 19, 2019...
Jul 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, July 30th. iRadimed management will host a conference call the same day beginning at...
Apr 30, 2019 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
iRadimed Corporation (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Apr 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30th.  IRADIMED management will host a conference call the same day beginning at...
Apr 11, 2019 07:15 am ET
Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion Financial, iRadimed, and Stewart Information Services — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Noble Energy Inc. (NYSE:NBL), American Vanguard Corporation (NYSE:AVD),...
Apr 02, 2019 07:00 am ET
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2”) monitoring features of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient...
Feb 06, 2019 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Jan 22, 2019 07:10 am ET
IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market opens on Wednesday, February 6th. IRADIMED management will host a conference call the same day beginning...
Jan 22, 2019 07:00 am ET
IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue After Temporarily Suspending Shipments of MRI Compatible Patient Vital Signs Monitoring Systems in European Markets
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices today announced that it temporarily suspended sales of its 3880 MRI compatible patient vital signs monitoring systems...
Dec 19, 2018 07:00 am ET
IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced FDA 510(k) clearance of its 3883 MRI-compatible invasive blood pressure module for use with its 3880...
Nov 16, 2018 07:20 am ET
New Research Coverage Highlights Beasley Broadcast Group, Resolute Energy, Hanger, Inspired Entertainment, Saratoga Investment, and iRadimed — Consolidated Revenues, Company Growth, and Expectations f
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Beasley Broadcast Group, Inc. (NASDAQ:BBGI), Resolute Energy Corporation...
Oct 30, 2018 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Oct 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market opens on Tuesday, October 30th.  IRADIMED management will host a conference call the same day beginning at...
Sep 11, 2018 07:00 am ET
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced receipt of regulatory clearance from the Japanese Ministry of Health Labor Welfare for the IRADIMED...
Jul 31, 2018 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is designed to be safe for...
Jul 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 Second Quarter Financial Results Conference Call on July 31st
IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 second quarter financial results before the market opens on Tuesday, July 31st. IRADIMED management will host a conference call the same day beginning at...
Apr 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 First Quarter Financial Results Conference Call on April 30th
WINTER SPRINGS, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, April 30th.  IRADIMED management will host a conference...
Mar 05, 2018 07:00 am ET
IRADIMED CORPORATION to Present at 30th Annual Roth Conference
WINTER SPRINGS, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer, will present at the 30th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled to...
Feb 06, 2018 08:45 am ET
iRadimed Corp to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 6, 2018 / iRadimed Corp (NASDAQ: IRMD) will be discussing their earnings results in their Q4 Earnings Call to be held on February 6, 2018 at 11:00 AM Eastern Time.
Feb 06, 2018 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2017 Financial Results
WINTER SPRINGS, Fla., Feb. 06, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of non-magnetic intravenous (“IV”) infusion pump systems that...
Jan 26, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2017 Fourth Quarter Financial Results Conference Call on February 6th
WINTER SPRINGS, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, February 6th.  IRADIMED management will host a conference...
Jan 22, 2018 07:00 am ET
IRADIMED CORPORATION Announces 2018 Annual and First Quarter Financial Guidance
WINTER SPRINGS, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (MRI) medical devices and the only known provider of a non-magnetic intravenous (IV) infusion pump system...
Sep 18, 2017 03:00 pm ET
IRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference
WINTER SPRINGS, Fla., Sept. 18, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference in New York, NY.  Mr. Susi and Mr. Scott are scheduled to present on Tuesday, September 26th at 3:25 pm Eastern Time....
Jul 17, 2017 10:30 am ET
IRADIMED CORPORATION to Hold 2017 Second Quarter Financial Results Conference Call on July 28th
WINTER SPRINGS, Fla., July 17, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 second quarter financial results before the market opens on Friday, July 28th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Mar 01, 2017 07:00 am ET
IRADIMED CORPORATION to Present at 29th Annual Roth Conference
WINTER SPRINGS, Fla., March 01, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the 29th Annual Roth Conference in Laguna Niguel, CA.  Mr. Susi and Mr. Scott are scheduled to present on Monday, March 13th at 11:00 am Pacific Time (2:00 pm Eastern Time)....
Oct 28, 2016 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2016 Financial Results
Reports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14 WINTER SPRINGS, Fla., Oct. 28, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three and nine months ended September 30, 2016. ...
Oct 18, 2016 08:30 am ET
IRADIMED CORPORATION to Hold 2016 Third Quarter Financial Results Conference Call on October 28th
WINTER SPRINGS, Fla., Oct. 18, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 third quarter financial results before the market opens on Friday, October 28th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Oct 04, 2016 06:55 am ET
IRADIMED CORPORATION Revises Financial Guidance for the Third Quarter and Full Year 2016
WINTER SPRINGS, Fla., Oct. 04, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today revised its third quarter and full year 2016 financial guidance....
Jul 29, 2016 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results
Revenue grows 29.7% compared to the same quarter last yearReports second quarter 2016 GAAP diluted EPS of $0.19 and non-GAAP diluted EPS of $0.24Increases full year 2016 non-GAAP earnings guidanceSubmits patient vital signs monitor 510(k) application to FDA for review WINTER SPRINGS, Fla., July 29, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three and six months en...
Jul 15, 2016 08:30 am ET
IRADIMED CORPORATION to Hold 2016 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 15, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 second quarter financial results before the market opens on Friday, July 29th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Jun 28, 2016 04:00 pm ET
IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board of Directors
WINTER SPRINGS, Fla., June 28, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Jonathan Kennedy has been appointed to the Company’s Board of Directors....
Jun 14, 2016 04:00 pm ET
IRADIMED CORPORATION Announces Election of Roger Susi as Chairman of the Board
WINTER SPRINGS, Fla., June 14, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that its Board of Directors voted unanimously to appoint current President and Chief Executive Officer, Roger Susi, as Chairman of the Board.  The appointment was effective as of the Annual Shareholders’ Meeting held on June 10, 2016.  Mr. Susi’s appointment is the result of the resignation of Jim Hawkins from the Company’s Board of Directors that was effective as of the date of the Annual Shareholders’ Meeting. ...
Jun 09, 2016 07:00 am ET
IRADIMED CORPORATION Provides Regulatory Update
WINTER SPRINGS, Fla., June 09, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD)...
Apr 29, 2016 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2016 Financial Results
Revenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance WINTER SPRINGS, Fla., April 29, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended March 31, 2016. ...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.